These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6206179)

  • 1. Molecular localization of human class II MT2 and MT3 determinants.
    Hurley CK; Giles RC; Nunez G; DeMars R; Nadler L; Winchester R; Stastny P; Capra JD
    J Exp Med; 1984 Aug; 160(2):472-93. PubMed ID: 6206179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.
    Sorrentino R; Lillie J; Strominger JL
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3794-8. PubMed ID: 2582424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
    Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
    J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
    Shackelford DA; Strominger JL
    Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdependent membrane mobility of human MHC coded antigens detected by monoclonal antibodies to various epitopes on class I and II molecules.
    Neppert J; Mueller-Eckhardt C
    Tissue Antigens; 1985 Jul; 26(1):51-9. PubMed ID: 2412307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different.
    Schiffenbauer J; Bono C; Schwartz BD
    Hum Immunol; 1985 Apr; 12(4):223-33. PubMed ID: 3872866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
    Nuñez G; Stastny P
    Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody.
    Falk JA; Lewis WH; Letarte M
    Hum Immunol; 1985 Aug; 13(4):265-80. PubMed ID: 2411699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional gel electrophoretic analysis of the MT3 and DR4 molecules from the different D-typed cells.
    Suzuki M; Yabe T; Satake M; Juji T; Hamaguchi H
    J Exp Med; 1984 Sep; 160(3):751-8. PubMed ID: 6206187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM; Moriuchi J; Winchester R; Silver J
    Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the MT3 molecule using two-dimensional gel electrophoresis and alloantisera.
    Suzuki M; Maeda H; Mukai R; Yabe T; Hamaguchi H
    Immunogenetics; 1983; 18(6):575-83. PubMed ID: 6197369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4.
    Lee SH; Gregersen PK; Shen HH; Nunez-Roldan A; Silver J; Winchester RJ
    Rheumatol Int; 1984; 4 Suppl():17-23. PubMed ID: 6085817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.